---
title: "EVO.US (EVO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EVO.US/news.md"
symbol: "EVO.US"
name: "EVO.US"
parent: "https://longbridge.com/en/quote/EVO.US.md"
datetime: "2026-03-08T10:24:01.408Z"
locales:
  - [en](https://longbridge.com/en/quote/EVO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EVO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EVO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/EVO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/EVO.US/news.md)


# EVO.US (EVO.US) — Related News

### [Evotec AG (NASDAQ:EVO) Receives Average Rating of "Hold" from Brokerages](https://longbridge.com/en/news/274664493.md)
*2026-02-03T13:27:28.000Z*
> Evotec AG (NASDAQ:EVO) has received a consensus "Hold" rating from five brokerages. One analyst rated it as a sell, one 

### [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://longbridge.com/en/news/274651779.md)
*2026-02-03T12:05:36.000Z*
> In Tuesday's pre-market session, Liminatus Pharma (NASDAQ:LIMN) saw a significant gain of 28.5%, reaching $0.73, while C

### [Evotec SE Management Board Member Dr. Cord Dohrmann sells 3,653 shares for EUR 22,925.99](https://longbridge.com/en/news/274340447.md)
*2026-01-30T17:14:06.000Z*
> Dr. Cord Dohrmann, a member of Evotec SE's Management Board, sold 3,653 shares at a price of 6.28 EUR each, totaling 22,

### [Evotec SE Managing Board Member Dr. Cord Dohrmann acquires shares worth EUR 42,425.33 through Share Performance Plan vesting](https://longbridge.com/en/news/274339964.md)
*2026-01-30T17:08:02.000Z*
> Dr. Cord Dohrmann, a managing board member of Evotec SE, acquired 6,760 shares through the vesting of the Share Performa

### [Evotec SE Announces 177,877,782 Total Voting Rights](https://longbridge.com/en/news/274322153.md)
*2026-01-30T14:06:01.000Z*
> Evotec SE has announced a total of 177,877,782 voting rights following a conditional capital increase effective January 

### [JPMorgan Chase & Co. reduces total voting rights in Evotec SE to 4.30%](https://longbridge.com/en/news/273484905.md)
*2026-01-23T08:18:10.000Z*
> JPMorgan Chase & Co. has reduced its voting rights in Evotec SE from 4.45% to 4.30%, a decrease of 0.15 percentage point

### [JPMorgan Chase & Co. decreases total voting rights in Evotec SE](https://longbridge.com/en/news/273209583.md)
*2026-01-21T09:50:49.000Z*
> JPMorgan Chase & Co. has reduced its voting rights in Evotec SE from 4.73% to 4.45%, a decrease of 0.28 percentage point

### [Evotec Discloses Increased Goldman Sachs Stake After Crossing Voting-Rights Threshold](https://longbridge.com/en/news/272835978.md)
*2026-01-16T12:28:27.000Z*
> Evotec AG announced that Goldman Sachs crossed a voting rights threshold, increasing its stake in the company to 6.12% f

### [Goldman Sachs Group reduces total voting rights in Evotec SE to 3.68%](https://longbridge.com/en/news/272814436.md)
*2026-01-16T09:37:07.000Z*
> Goldman Sachs Group has reduced its voting rights in Evotec SE from 5.27% to 3.68%, a decrease of 1.59 percentage points

### [MAK Capital Fund LP increases total voting rights in Evotec SE to 5.17%](https://longbridge.com/en/news/272814067.md)
*2026-01-16T09:34:44.000Z*
> MAK Capital Fund LP, led by Michael Kaufman, has increased its voting rights in Evotec SE to 5.17%. The stake in shares